SCHEMBL6660145

SCHEMBL6660145

CC(C)C[C@H](NNC(=O)c1cc2ccccc2s1)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.64
TAS1R1 Q7RTX1 2/20 0.64
PIN1 Q13526 3/20 0.53
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52
CTSK P43235 5/20 0.51
OPRM1 P35372 4/20 0.49
RAB9A P51151 1/20 0.49
CTSB P07858 1/20 0.48
CTSS P25774 1/20 0.48
BCL2L1 Q07817 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3078403 0.88 TAS1R3 (0.78) TAS1R3TAS1R1PIN1HDAC3HDAC4
SCHEMBL704949 0.88 TAS1R3 (0.78) TAS1R3TAS1R1PIN1HDAC3HDAC4
SCHEMBL14362858 0.80 TAS1R3 (0.78) TAS1R3TAS1R1PIN1HDAC3HDAC4
SCHEMBL14360883 0.78 HDAC3 (0.59) TAS1R3TAS1R1HDAC3HDAC4HDAC1
SCHEMBL7241995 0.78 TAS1R3 (1.00) TAS1R3TAS1R1PIN1HDAC3HDAC4
SCHEMBL4192862 0.78 TAS1R3 (1.00) TAS1R3TAS1R1PIN1HDAC3HDAC4
SCHEMBL10226447 0.78 TAS1R3 (1.00) TAS1R3TAS1R1PIN1HDAC3HDAC4
SCHEMBL14605678 0.78 TAS1R3 (0.70) TAS1R3TAS1R1PIN1HDAC3HDAC4
SCHEMBL8237060 0.75 HDAC3 (0.55) TAS1R3TAS1R1HDAC3HDAC4HDAC1
SCHEMBL3913711 0.75 PIN1 (0.64) TAS1R3TAS1R1PIN1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200457-B1 CYSTEINE PROTEASE INHIBITORS NAEJA PHARMACEUTICAL INC (CA) 2004-08-25 EP disclosed
US-6635621-B1 Alpha amino acid amide derivatives; reducing cathepsins B, L, S and/or K activity NAEJA PHARMACEUTICAL INC. (CA) 2003-10-21 US disclosed